Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Allantoic Split Inactivated Seasonal Influenza Vaccine in Healthy Adults
NCT03016143Phase 2Completed
- Sponsor
- Research Institute for Biological Safety Problems
- Start
- Oct 2016
- Primary completion
- Nov 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ARCT-2138 in influenza, sponsored by Research Institute for Biological Safety Problems. Started Oct 2016; status: completed.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03016143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016143.